五鼎生物技術股份有限公司


History

2016 Apr. - Passed 4th FDA on-site inspection

2015 Oct. - Outstanding Category Awards of APEA 2015 ( Asia Pacific Entrepreneurship Awards )

2014 Dec. - Authorized Economic Operator (AEO) by Customs Admin, Ministry of Finance

2013 Feb. - 1st Taiwan MITTELSTAND Award from the MOEA

2012 Jan. - FDA approval of「CAL-1A」

2011 Apr. - FDA approval of AutoSure Voice 3 system

2010 Jan. - Local ERP system changed into Oracle JDE

2009 Mar. - to be selected Taiwan A+ Entrepreneur by Global Views

2008 Mar. - FDA 510 (k) approval of the GlucoSure Voice Blood Glucose Monitoring System

2007 Oct. - Awarded by Forbes Asia as "200 Best under a billion"

2006 Oct. - Awarded by Forbes Asia as "200 Best under a billion"

2005 July - Move-in New Facility

2004 Aug. - Co-Development of Bioluminescence Microsystems with ITRI

2003 Nov. - Purchasing of a new facility (23,867 M2)

2002 May - MultiSure Glucose & Uric Acid System Product Launch

2001 Sept. - Listed on the Taiwan Stock Exchange (stock code 1733)

2000 June - Listed on the Taiwan Over-The-Counter Securities Exchange

1999 April - GlucoSure Blood Glucose Monitoring System launch

1998 Nov. - Sensorex Blood Monitoring System wom "Product of the year" on Mediphar, Taipei

1997 Dec. - ApexBio founded in HsinChu Science Park

1996 June - Sensores system won "Gold National Award of Excellence"
This website uses cookies to customize your experience, and please see more details at Cookie Statement.
By using this website, you will be deemed to have agreed the cookie services as below.

Google Analytics (universal)      + More     + Check The Official Website      Accept Reject
五鼎生物技術 ApexBio Taiwan